DBV Technologies (FRA:DBV) FFO


FRA:DBV DBV Technologies SA FRA:DBV
27 GF Score
Price €2.77
! 1 Warning Sign
View Full Analysis

What is DBV Technologies FFO?

FFO (Funds from operations) only applies to REITs.

FRA:DBV
27GF Score
DBV Technologies SA FRA:DBV
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DBV Technologies Business Description

Address 107 Avenue de la Republique, Batiment IRO, Chatillon, Paris, FRA, 92320
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
27GF Score

Get the complete analysis for FRA:DBV

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.77
Price